Share
Journal Information
Most Often Read
34755
Skin manifestations of liver diseasesA. Koulaouzidis;, S. Bhat;, J. Moschos
Ann Hepatol. 2007;6:181-4
34755
Open access
10773
Shark liver oil: hidden dangersSerta Kilincalp, Murat Deveci, Omer Basar, Fuat Ekiz, Sahin Coban, Osman Yuksel
Ann Hepatol. 2012;11:728-30
10773
Open access
5872
Current concepts in acute liver failureMaximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol. 2019;18:543-52
5872
Open access
5193
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)Juan P. Arab, Juan P. Roblero, Jose Altamirano, Fernando Bessone, Roberta Chaves Araujo, Fatima Higuera-De la Tijera, Juan Carlos Restrepo, Aldo Torre, Alvaro Urzua, Douglas A. Simonetto, Juan G. Abraldes, Nahum Méndez-Sánchez, Fernando Contreras, Michael R. Lucey, Vijay H. Shah, Helena Cortez-Pinto, Ramon Bataller
Ann Hepatol. 2019;18:518-35
5193
Open access
4439
Diagnosis of liver nodules within and outside screening programsMassimo Colombo
Ann Hepatol. 2015;14:304-9
4439
Open access
3581
Report of the Baveno VI Consensus WorkshopAndres Cardenas, Angela Mendez-Bocanegra
Ann Hepatol. 2016;15:289-90
3581
Open access
3517
Transmission routes of hepatitis C virus infectionEduardo Zumaeta Villena
Ann Hepatol. 2006;5 Supl 1:S12-4
3517
Open access
3457
Multiple Biliary Hamartomas, The ‘‘Von Meyenburg Complexes’’Joel O. Jáquez-Quintana, Erick A. Reyes-Cabello, Francisco J. Bosques-Padilla
Ann Hepatol. 2017;16:812-3
3457
Open access
3356
Management Strategies for Liver FibrosisAlejandra Altamirano-Barrera, Beatriz Barranco-Fragoso, Nahum Méndez-Sánchez
Ann Hepatol. 2017;16:48-56
3356
Open access
3280
Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathyClaudia Isabel Blanco Vela, Jorge Luis Poo Ramírez
Ann Hepatol. 2011;10 Supl 2:S55-9
3280
Open access
3208
Treatment of hyperferritinemiaMelanie D. Beaton, Paul C. Adams
Ann Hepatol. 2012;11:294-300
3208
Open access
3184
Acute liver injury, acute liver failure and acute on chronic liver failure: A clinical spectrum of poisoning due to Gyromitra esculentaMagdalena Arłukowicz-Grabowska, Maciej Wójcicki, Joanna Raszeja-Wyszomirska, Monika Szydłowska-Jakimiuk, Bernard Piotuch, Piotr Milkiewicz
Ann Hepatol. 2019;18:514-6
3184
Open access
3180
New Insights About Albumin and Liver DiseaseJoana R. Carvalho, Mariana Verdelho Machado
Ann Hepatol. 2018;17:547-60
3180
Open access
2839
AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosisAurora Loaeza-del-Castillo, Francisco Paz-Pineda, Edgar Oviedo-Cárdenas, Francisco Sánchez-Ávila, Florencia Vargas-Vorácková
Ann Hepatol. 2008;7:350-7
2839
Open access
2694
Fontan-Associated Liver Disease: A ReviewLuis Téllez, Enrique Rodríguez-Santiago, Agustín Albillos
Ann Hepatol. 2018;17:192-204
2694
Open access
2531
The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver diseaseDaniel Iluz-Freundlich, Manna Zhang, Julia Uhanova, Gerald Y. Minuk
Ann Hepatol. 2020;19:204-8
2531
Open access
2524
Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compoundsRenata Koníčková, Kateřina Vaňková, Jana Vaníková, Katerina Vánová, Lucie Muchová, Iva Subhanová, Marie Zadinová, Jaroslav Zelenka, Ales Dvořák, Michal Kolář, Hynek Strnad, Silvie Rimpelová, Tomas Ruml, Ronald J. Wong, Libor Vítek
Ann Hepatol. 2014;13:273-83
2524
Open access
2435
The liver in times of COVID-19: What hepatologists should knowEzequiel Ridruejo, Alejandro Soza
Ann Hepatol. 2020;19:353-8
2435
Open access
Open Article
2341
Portal vein thrombosis: What is new?María del Carmen Manzano-Robleda, Beatriz Barranco-Fragoso, Misael Uribe, Nahum Méndez-Sánchez
Ann Hepatol. 2015;14:20-7
2341
Open access
Special content about COVID-19
Publish in
Annals of Hepatology
Affiliated societies
